[Asia Economy Reporter Lee Seon-ae] Enzen Bio announced on the 26th that it recorded an operating loss of 1,451.22 million KRW on a consolidated basis for the second quarter. This is an improvement compared to the same period last year (operating loss of 2,398.02 million KRW).



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing